Balchem Corporation reported strong third quarter financial results with solid revenue growth and record earnings from operations and adjusted EBITDA. Net sales were $239.9 million, net earnings were $33.8 million, adjusted EBITDA was $64.4 million, and free cash flow was $42.2 million.
Net sales increased by 4.3% compared to the prior year quarter, reaching $239.9 million.
Adjusted EBITDA reached a record $64.4 million, a 7.6% increase from the prior year quarter.
GAAP net earnings increased by 16.4% from the prior year quarter, totaling $33.8 million.
The company saw strong sales growth and earnings from operations in both the Human Nutrition and Health and Specialty Products segments.
The Balchem team delivered another strong quarter, highlighting the resilience of the business model and remains confident in the long-term growth outlook.
Visualization of income flow from segment revenue to net income